Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,926–4,950 of 7,816 matching trials · page 198 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein NCT03071224 [18F] MNI-946; [18F]Florbetapir Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 10 | Invicro OTHER |
2021-06-14 |
|
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior NCT00663871 Fish Oil; Soybean Oil (Placebo) Runs in: United States · 1 site |
NA other |
COMPLETED | 272 | University of Pittsburgh OTHER |
2021-06-11 |
|
Study for Cognitive and Genetic Characterization of a 45-65 Years Old Population NCT01835717 Runs in: Spain · 1 site |
NA other |
COMPLETED | 2,743 | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation OTHER |
2021-06-10 |
|
Doll Therapy in Dementia NCT04920591 doll treatment Runs in: Italy · 1 site |
NA other |
COMPLETED | 104 | Centre Hospitalier Universitaire Vaudois OTHER |
2021-06-10 |
|
Virtual Environment to Aid Cognitive Stimulation of Elderly People With Early Alzheimer's NCT04919005 Virtual Environment Runs in: Brazil · 1 site |
NA other |
COMPLETED | 34 | University of Mogi das Cruzes OTHER |
2021-06-09 |
|
Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial) NCT04916964 Test and exercise home-based program Runs in: Switzerland · 1 site |
NA other |
UNKNOWN | 12 | HES-SO Valais-Wallis OTHER |
2021-06-08 |
|
EEG and TMS-based Biomarkers of ALS, MS and FTD NCT04918251 128 electrode electroencephalography (EEG); Transcranial magnetic s... Runs in: Ireland · 1 site |
NA other |
UNKNOWN | 400 | University of Dublin, Trinity College OTHER |
2021-06-08 |
|
CLearing Alzheimer's Disease Molecular Pathology Without Medications NCT04913454 40 Hz multi-sensory (auditory + visual) stimulation and cognitive t... |
NA other |
UNKNOWN | 20 | University Hospital, Geneva OTHER |
2021-06-04 |
|
Transcranial Direct Current Stimulation for Primary Progressive Aphasia NCT02928848 transcranial direct current stimulation Runs in: United States · 1 site |
NA other |
COMPLETED | 16 | University of Pennsylvania OTHER |
2021-06-03 |
|
Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease NCT01409915 Sagramostim; Saline -- placebo comparator Runs in: United States · 1 site |
PHASE2 anti-inflammatory |
COMPLETED | 44 | University of Colorado, Denver OTHER |
2021-06-02 |
|
Effect of Provision of Information and Supportive Nursing Care: A Randomised Controlled Trial NCT04834037 Behavioral Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 60 | Ondokuz Mayıs University OTHER |
2021-06-02 |
|
2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension) NCT02916056 Azeliragon 5mg Runs in: Canada; United States · 71 sites |
PHASE3 other |
TERMINATED | 297 | vTv Therapeutics INDUSTRY |
2021-06-01 |
|
Assessment of Effectiveness and Safety of Transcranial Magnetic Stimulation (rTMS) Combined With Transcranial Direct Current Stimulation (tDCS) in Dementia Treatment in Alzheimer's Disease NCT04823819 Magnetic Stimulator DuoMag; neuroConn DC-STIMULATOR Runs in: Poland · 1 site |
NA other |
UNKNOWN | 40 | Medical University of Lodz OTHER |
2021-05-27 |
|
Positive Psychotheraphy and Antisocial Personality Disorder: Crime, Aggression, Anger NCT04903938 Primary And Secondary Abilities Among The Individuals With Antisoci... |
NA other |
COMPLETED | 3 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey OTHER |
2021-05-27 |
|
Effects of Enriched Gardens in Nursing Home Residents With Dementia NCT04903171 INCENTIVE VISITING A GARDEN : ENRICHED OR CONVENTIONAL SENSORY GARDEN Runs in: France · 1 site |
NA other |
COMPLETED | 130 | RIVAGES OTHER |
2021-05-26 |
|
An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease NCT02537626 Erchonia ALS Laser; Placebo Laser Runs in: Mexico · 2 sites |
NA other |
COMPLETED | 43 | Erchonia Corporation INDUSTRY |
2021-05-25 |
|
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study NCT03783754 telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg; Placebo o... Runs in: Australia · 3 sites |
NA other |
TERMINATED | 4 | The George Institute OTHER |
2021-05-25 |
|
Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Patients With Mild Cognitive Impairments NCT01782391 Stimulation; SHAM Runs in: Germany · 1 site |
NA other |
WITHDRAWN | 0 | Charite University, Berlin, Germany OTHER |
2021-05-24 |
|
Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS NCT02110043 tDCS; training Runs in: Germany · 1 site |
NA other |
COMPLETED | 21 | Charite University, Berlin, Germany OTHER |
2021-05-21 |
|
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) NCT02365922 Runs in: Canada; United States · 17 sites |
NA other |
COMPLETED | 1,489 | University of California, San Francisco OTHER |
2021-05-21 |
|
Validation Study of a New Digital Treatment Test NCT04897464 BGaze therapy Alzheimer Runs in: Spain · 1 site |
NA other |
UNKNOWN | 60 | Braingaze INDUSTRY |
2021-05-21 |
|
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease NCT00818662 Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg; Imm... Runs in: Canada; United States · 41 sites |
PHASE3 other |
COMPLETED | 390 | Baxalta now part of Shire INDUSTRY |
2021-05-19 |
|
Phase 3 IGIV, 10% in Alzheimer´s Disease NCT01524887 Immune Globulin Intravenous (Human), 10% Solution; Human albumin 0.25% Runs in: Australia; Belgium; Canada; Japan; Poland; Spain; United ... · 69 sites |
PHASE3 other |
TERMINATED | 508 | Baxalta now part of Shire INDUSTRY |
2021-05-19 |
|
Long-Term Study of IGIV, 10% in Alzheimer´s Disease NCT01736579 Immune Globulin Intravenous (Human), 10% (IGIV, 10%) Runs in: United States · 1 site |
PHASE3 other |
TERMINATED | 6 | Baxalta now part of Shire INDUSTRY |
2021-05-19 |
|
Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia NCT03422250 transcranial direct current stimulation (tDCS) Runs in: Italy · 1 site |
NA other |
COMPLETED | 45 | IRCCS Centro San Giovanni di Dio Fatebenefratelli OTHER |
2021-05-19 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial